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668Objective: Intraoperative cerebral events are mainly caused by emboli generated by operative manipulation of
the aorta. This study aimed to delineate the distribution profiles of emboli with 2 widely used cannulae and a
third novel research cannula that simultaneously produces forward flow and backward suction to extract emboli
from the distal aorta during cardiac surgery.
Methods: The current in vitro study used a silicone model of the aortic arch and branches. The main outcome
measure was the distribution profile of embolic particles of different sizes to the aortic branches; 2 commercial
cannulae and a third novel cannula with and without suction were used. The research cannula was examined at
different suction levels and the amount of particles retrieved was measured.
Results: For the research curved-tip cannula, most of the small emboli were released into the brachiocephalic
trunk in the model (P< .05). For the straight-tip cannula, most of the small emboli were released into the
descending aorta (P<.05). Regarding the commercial curved-tipped cannula, most of the small emboli were
released into the brachiocephalic trunk (47.14%  4.78%; P<.05) and the medium and large emboli were
predominantly released into the descending aorta. Using suction, the research cannula retrieved most of the
emboli released into the aorta for all particle sizes (50%-83%; P<.05).
Conclusions: A straight-tip cannula may be safer in terms of cerebral embolic consequences during cardiac
surgery. Furthermore, the use of the research aortic cannula may be beneficial in the cardiac surgery setting
by reducing the postoperative risk for stroke. (J Thorac Cardiovasc Surg 2014;148:668-75)The risk of neurologic injury is significant for patients
undergoing cardiac surgery and is associated with increased
mortality, morbidity, hospital costs, and impaired quality
of life.1 Cardiac surgery involves a wide spectrum of
neurologic injuries, including ischemic stroke, occurring
in 1.5% to 5.2% of patients; encephalopathy, affecting
8.4% to 32% of patients; and neurocognitive dysfunction,
manifested in 20% to 30% of patients 1 month after
surgery.2,3 Embolism is considered the main mechanism
of neurologic injury.4
Emboli can be divided intomacro andmicro categories ac-
cording to size. Macroemboli occlude flow in arteries 200
mm or greater in diameter, whereas microemboli occlude
flow in smaller arteries, arterioles, and capillaries.5 Thirty
to fifty percent of perioperative strokes detected with brain
imaging are caused by a cerebral macroembolism likely
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The Journal of Thoracic and Cardiovascular Surgneurocognitive dysfunction are believed to result primarily
from cerebral microembolisms,5,9 which are either gaseous
or particulate in composition. Gaseous emboli can arise
from an open left-sided cardiac chamber or from air en-
trained into the cardiopulmonary bypass (CPB) circuit.2 An
increased rate of embolic material released into the cerebral
circulation has been detected during various aorticmanipula-
tions performed in cardiac surgery (eg, aortic crossclamp
placement and removal, aortic cannulation, and side-biting
clamping for proximal coronary artery anastomosis).10-12
The aim of the current study was to assess 2 commercial
cannulae and a third new aortic cannula with and without
suction. The novel cardiac cannula simultaneously induces
forward flow and backward suction to remove solid and
gaseous emboli from the distal aorta on their release during
cardiac surgery.MATERIALS AND METHODS
Description of the Commercial and Research Aortic
Cannulae
The current study compared the properties of 3 different aortic
cannulae; 2 commercial cannulae and the research cannula. The 2 commer-
cial cannulae included (1) a straight-tip 24-Fr aortic cannula (DLP straight
tip arterial cannula; Medtronic, Inc, Minneapolis, Minn); and (2) a curved-
tip (45) 24-Fr aortic cannula (ARS024CS; Edwards Lifesciences, Irvine,
Calif). The research cannula was a curved-tip (60) 24-Fr aortic cannula
(CardioGard; BEL Bioengineering Laboratories, Cantu, Italy).
The novel research cannula comprises 2 hollow cylinders (Figure 1);
the first cylinder is a standard main forward-flow tube administeringery c August 2014
FIGURE 1. The cannulae used in the study.
Shani et al Evolving Technology/Basic Sciencearterial blood into the aorta from the bypass machine. The second
cylinder, which is attached to an existing bypass vent port, is a novel
element located posterior to the main tube. Its function is to facilitateFIGURE 2. The silicone in vitro model of the aorta. The upper 3 exits simul
(3) the left subclavian artery. The lower exit simulates the descending aorta (D
The Journal of Thoracic and Cablood and particle suction by directing the blood back to the reservoir
of the bypass machine, while the evacuated emboli material is eliminated
through a filter.ate (1) the brachiocephalic trunk, (2) the left common carotid artery, and
A).
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FIGURE 3. A-C, Description and comparison of the amount (in milligrams) of emboli released in the various branches of the experimental model without
suction, according to the size of the particles and the type of cannula (namely, [C1] straight-tip cannula, [C2] curved-tip 45cannula, and [C3] curved-tip
60 cannula, CardioGard). The upper 3 exits simulate (1) the brachiocephalic trunk, (2) the left common carotid artery, and (3) the left subclavian artery. The
lower exit simulates the descending aorta (DA). The tables represent significant differences (P<.05), denoted byþ, between theweight of emboli filtered by
the various cannulae at the various exits.
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A silicone model of the aorta with its 3 arch branches was constructed
(Figure 2). A fourth exit simulated the descending aorta. A 70-mm diameter
filter was placed at each exit to capture solid and gaseous embolic material.
A mixed fluid composed of 80% water and 20% glycerin was used to
simulate blood.670 The Journal of Thoracic and Cardiovascular SurgInjection Procedure
Bovine bone was ground into particles of 100 to 1000 mm. Solid
emboli material (120 mg) of 3 different sizes were injected: (1) 100 to
250 mm in diameter in the first session; (2) 250 to 500 mm in the second
session; and (3) 500-1000 mm in the third session. Embolic material was
placed between 2 clamps in the proximal silicone aorta. Both clampsery c August 2014
FIGURE 3. (continued).
Shani et al Evolving Technology/Basic Sciencewere released simultaneously. Flow was set to 4 L/min for nonsuction
conditions and 4.5 L/min for the suction experiments. Every injection
procedure was repeated 8 times. At the end of every cycle, the filters
were washed and the embolic material at every exit was weighed. The
research cannula was examined under different levels of suction flow
(0, 0.5, 1, and 1.5 L/min).
Statistical Analysis
All analyses were conducted using the Statistical Package for the
Social Sciences, Version 19 (SPSS Inc., Chicago, Ill). Data are presented
as means  standard deviation (SD). Analyses of variance and post hoc
Tukey tests were used to compare the amount of emboli material retrieved
at the various exits across the different particle sizes using the various
cannulae.E
T
/B
SRESULTS
Description of the Distribution Profiles of the Emboli
for the Various Cannulae
For the straight-tip cannula, most of the emboli were
released into the descending aorta for the small and medium
particles (74.3  11.0 mg, 53.6  6.0 mg, respectively;
P<.05); for the large particles, the emboli were predomi-
nantly released into the brachiocephalic trunk (52.3  8.4
mg; P<.05). Figure 3 describes and compares the weight
of the emboli released in the various branches of the
experimental model without suction, according to the size
of particles and type of cannula.
For the curved-tipped cannula (no. 2), most of the
small particles were released into the brachiocephalic trunk
(56.5  5.8 mg; P<.05); the medium and large particles
were predominantly released into the descending aorta
(60.8  11.2 mg, 46.1  5.9 mg, respectively; P<.05).The Journal of Thoracic and CaThe distribution profile of the research cannula
was similar for all particle sizes; most emboli were
released into the brachiocephalic trunk (48.1  7.3 mg,
61.2  14.0 mg, 51.5  13.8 mg, respectively; P<.05).The Research Cannula: Comparison of the Various
Suction Levels
The use of the suction function of the research cannula,
regardless of its intensity and for all particle sizes,
enabled the retrieval of a considerable amount of emboli
from the aorta. Figure 4 describes the weight of emboli
released in the various branches of the experimental
model with suction, according to the size of the released
particles. The amount of filtered emboli significantly
increased with higher suction levels, for all particle
sizes: 60.1  5.4 mg to 100.1  6.6 mg for the small
particles; 62.3  4.6 mg to 95.0  4.2 mg for the
medium particles; and 60.0  3.6 mg to 95.3  5.9 mg
for the large particles (P< .05). For each suction level,
the amount of particles retrieved was comparable for the
different particle sizes (P>.05).Comparison of the Straight, Curved Commercial and
Research (With Suction) Cannulae
Using the research cannula, the weight of emboli
caught in the brachiocephalic trunk and left common ca-
rotid artery was significantly reduced under all suction
conditions (P < .05). Figure 5 depicts the weight of
emboli filtered by the brachiocephalic trunk and left com-
mon carotid artery using the various cannulae by particlerdiovascular Surgery c Volume 148, Number 2 671
FIGURE 4. A and B, The amount of emboli released (in milligrams) the various branches of the experimental model (curved-tip 60 cannula, CardioGard)
with suction (1.5 L/min, 1.0 L/min, 0.5 L/min), according to size of particles in the novel research cannula. The amount of filtered emboli significantly
increased with higher suction levels for all particle sizes (P<.0001). The upper 3 exits simulate (1) the brachiocephalic trunk, (2) the left common carotid
artery, and (3) the left subclavian artery. The lower right exit simulates the descending aorta (DA) and the lower left exit simulates the suction function.
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significant decrease in the amount of embolic material
that was caught in these exits (straight tip, highest
amount; curved tip 60, smallest amount); (2) for the me-
dium (250-500 mm) and large (500-1000 mm) particles, a672 The Journal of Thoracic and Cardiovascular Surgcomparable amount of embolic material was caught using
the straight-tip and curved-tip 45 cannulae, and
compared with each of these cannula, the curved-tip
60 cannula captured a significantly smaller amount of
emboli.ery c August 2014
FIGURE 4. (continued).
Shani et al Evolving Technology/Basic ScienceDISCUSSION
The main finding of the current study is that the novel
research aortic cannula enabled the retrieval of most of
the embolic material released into the model aorta, suggest-
ing its potential for dramatically reducing the postoperative
risk for stroke.FIGURE 5. The amount of emboli (in milligrams) filtered by the
brachiocephalic trunk and left common carotid artery using the
various cannulae (namely, [1] straight-tip cannula, [2] curved-tip 45 can-
nula, and [3] curved-tip 60 cannula, CardioGard, 1.5 L/min), according to
size (100-250 mm, 250-500 mm, and 500-1000 mm). Comparisons were
conducted according to particle size (3 analyses of variance; P<.0001).
Tukey post hoc comparisons. *Significant difference between the curved-
tip cannula and the straight-tip cannula; NS denotes a nonsignificant differ-
ence between the curved-tip cannula and the straight-tip cannula. **Signif-
icant decrease in the weight of emboli captured using the research cannula
compared with the straight-tip and the curved-tip cannulae.
The Journal of Thoracic and Ca
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the Different Cannulae Without Suction
The distribution profiles of the straight, curved and the
novel research cannulae may be attributed to the physical
properties of the cannulae; namely, the larger the angle of
the cannula tip, the greater the chances of the emboli being
released into the upper part of the aorta, and specifically, the
first branch. The clinical significance of this observation is
that the straight-tip cannula may be associated with a
reduced risk of cerebral emboli. These findings are in
agreement Avrahami and colleagues13 who investigated
numerical models of different cannula orientations, aortic
anatomies, and cannula designs. Albert and colleagues14
studied the impact of the shape of aortic end-hole cannulae
on stroke occurrence and concluded that straight-tip
cannulae cause significantly more frequent and more
severe bilateral and posterior strokes than curved-tip
cannulae. Similar conclusions were presented by White
and colleagues15 who compared curved-tip cannulae with
standard straight-tip cannulae.Emboli Distribution of the Novel Aortic Cannula
With Suction
The novel aortic cannula enabled the retrieval of most
of the embolic material released into the model aorta, in
the range of 60 to 99.6 mg (50%-83%), for all particle
sizes. This finding proved the theoretic efficacy of
the cannula to reduce the risk of cerebral events during
cardiac surgery. Avrahami and colleagues16 conductedrdiovascular Surgery c Volume 148, Number 2 673
FIGURE 6. A, Blood flow stagnation between the cannula and the clamp may lead to the generation of embolic material through thrombus formation.
B, The novel cannula enables the elimination of blood flow stagnation and the removal of thrombotic material. Adapted with permission from Avrahami
and colleagues.13
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pared with straight-tip and curved-tip commercial cannulae
(the ones used in the current study), the novel aortic
cannula was associated with a significant improvement
in terms of potential risk of cerebral embolism, and
similar risks for other hemodynamic complications, such
as hemolysis or atheroembolism. Shani and colleagues17
investigated the novel aortic cannula in an in vivo
model and reported that in terms of safety and hemo-
compatibility, the novel aortic cannula was comparable
with the standard, widely used aortic cannula tested in the
current study, and demonstrated a reduced risk of cerebral
emboli.
The novel aortic cannula presented in the current study
was developed for the purpose of reducing cerebral events
after cardiac surgery, mainly by allowing the surgeon to
perform the surgical procedure within safer limits of aortic
manipulation, including crossclamp placement and removal
as well as proximal anastomosis.
The capacity of the research cannula to retrieve emboli is
enabled in several ways: (1) collection of embolic material
coming behind the suction orifice and generated by
manipulations of the aorta during the surgical procedure,
as well as air and solid particles released from the heart after
declamping of the aorta; (2) the cannula is eliminating
embolic material generated in the space between the
cannulation site and the aortic clamp as a result of
stagnation of blood flow, as demonstrated by Avrahami
and colleagues13 (Figure 6). This type of embolic material674 The Journal of Thoracic and Cardiovascular Surgis usually released into the systemic circulation after
declamping of the aorta.
Several types of devices used after cannulation minimize
the quantity of emboli released during cardiac surgery.
First, an ultrasound-based device that is placed on the aorta
during surgery is used to divert the released particles from
the cerebral circulation toward the descending aorta.18
Second, a percutaneously placed device inserted into the
right forelimb and deployed in the aorta19 performs a
similar action of diverting particles from the cerebral
circulation. Third, an intra-aortic filtration device in the
aortic cannula incorporates a filter that captures particulate
emboli during cardiopulmonary bypass.20
In comparison with existing devices for intraoperative
emboli reduction, the cannula under study is less invasive
and is based on complete emboli removal rather than their
deflection to the lower limbs, preventing ischemic events
within the systemic circulation, including the kidneys,
gastrointestinal system, and lower extremities.
Several limitations within the current study need to be
addressed. First, the study did not include cycles of injected
embolic material of mixed size, which may have portrayed
the systemic circulation more reliably. Second, because
current findings are based on an in vitro model, the ability
to generalize to the clinical setting is limited. Third, the
study was designed such that a fixed inflow was set but
the suction level ranged from 0.5 to 1.5 L/min, leading to
a corresponding variation in the net flow values. This
technical matter may have had an effect on the distributionery c August 2014
Shani et al Evolving Technology/Basic Scienceprofile of the embolic material in the silicone model
branches, such that more embolic material was captured
in the suction filter as the suction level increased; however,
maintaining a constant net flow would have probably given
rise to lower amounts of captured emboli. Third, the current
results were achieved under clamp-release conditions,
relevant to a small fraction of the surgical procedure, which
is significant in terms of emboli release.
In conclusion, the current findings support the use of
the novel aortic cannula in cardiac surgery for the
potential reduction in the rate of cerebral events. A
human, multicenter, randomized, controlled clinical trial
is currently under way.
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